The Wilms' tumor 1 (WT1) and sex-determining region of the Y chromosome (SRY) genes are essential for development of the mammalian gonads and mutations in these genes are associated with gonadal dysgenesis in humans. The SRY gene encodes a transcription factor with one high-mobility group (HMG) box as a DNAbinding domain. WT1 encodes a transcription factor that contains four contiguous C 2 H 2 -type zinc-finger motifs as a DNA/RNA binding or protein-protein interaction domain. Here we report that WT1 binds to and acts synergistically with SRY to activate transcription from a promoter containing SRY-binding sites. This interaction is mediated by the WT1 zinc-finger domain and the SRY HMG box. WT1 mutants associated with Denys-Drash syndrome (DDS), which is characterized by Wilms' tumor, pseudohermaphroditism, and nephropathy, fail to interact with SRY. Wildtype WT1 is recruited to SRYbinding sites in an SRY-dependent manner, whereas DDS mutants are not recruited as efficiently. These results suggest that WT1 forms a complex with SRY to regulate transcription and that this WT1-SRY interaction is important in testis development.
Development of the mammalian testis is regulated genetically, and the sex-determining region of the Y chromosome (SRY) gene plays a critical role in this process (Gubbay et al., 1990; Sinclair et al., 1990) . SRY mutations are found in 10-15% of XY females, and translocation of SRY onto the X chromosome or autosomes is observed in approximately 80% of XX males (McElreavey and Fellous, 1999) . In mouse embryos, mouse SRY (Sry) is expressed at 10.5-12.5 days postcoitum (d.p.c.) just before initiation of testis development Hacker et al., 1995) . Sry induces development of testes when introduced into female mouse embryos (Koopman et al., 1991) . The SRY gene encodes a transcription factor with one high-mobility group (HMG) box that binds to and bends the target DNA (Ferrari et al., 1992; Harley et al., 1994) . This DNA-binding activity is thought to be essential for testis development because mutations that disrupt DNA binding are observed in gonadal dysgenesis and XY sex reversal Pontiggia et al., 1994) . Vertebrate SRY genes are highly divergent, and the transcriptional activation domain has been identified only in Sry (Dubin and Ostrer, 1994; Koopman, 1999) . Therefore, the mechanism of transcriptional regulation by SRY remains unclear.
The WT1 gene was identified as a tumor-suppressor gene of Wilms' tumor (Call et al., 1990; Gessler et al., 1990) . Based on the observation of WT1-knockout mice, WT1 is required for the development of several organs, including kidney, gonad, spleen, adrenal gland, epicardium, and retina (Kreidberg et al., 1993; Herzer et al., 1999; Moore et al., 1999; Patek et al., 1999; Wagner et al., 2002a,b) . For testis development, WT1 is expressed in the somatic cells of developing gonads and is restricted to the Sertoli cells of the testis (Pelletier et al., 1991; Armstrong et al., 1993) . WT1 mutation is involved in human gonadal dysgenesis, which is observed in Denys-Drash syndrome (DDS) and Frasier syndrome (Scharnhorst et al., 2001) . The WT1 gene encodes a transcription factor with four contiguous C 2 H 2 -zinc-finger motifs at the C-terminus and a transcriptional regulatory region at the N-terminus. In all, 24 isoforms are generated by alternative splicing, alternative initiation sites, and RNA editing. Of particular interest is alternative splicing of exon 9 that generates a three amino-acid insertion (lysine-threonine-serine, KTS) between the third and fourth zinc fingers. This alternative splicing is conserved during evolution (Kent et al., 1995; Semba et al., 1996) , and WT1 lacking KTS (WT1ÀKTS) and WT1 containing KTS (WT1 þ KTS) have distinct biological functions during sex determination and nephron formation (Hammes et al., 2001) . WT1 binds directly to 9-12 base GC-rich consensus sequences and regulates transcription (Rauscher et al., 1990; Drummond et al., 1994; Nakagama et al., 1995) . In gonad development, WT1 is thought to regulate transcription of the orphan nuclear receptor Dax-1 and SRY genes via its direct binding to DNA (Shimamura et al., 1997; Kim et al., 1999; Hossain and Saunders, 2001 ). Furthermore, WT1 also functions as a transcriptional cofactor for a transcription factor. WT1-KTS associates and acts synergistically with Ad4BP/SF-1 to promote expression of the Mu¨llerian-inhibiting substance (MIS) gene, which triggers regression of the Mu¨llerian duct in males, without binding directly to the MIS gene promoter (Nachtigal et al., 1998) .
Previously, we identified a novel HMG box containing protein Sox30, which interacts with WT1, by yeast two-hybrid screening (Osaki et al., 1999) . Since WT1 binds to the HMG box of Sox30 (unpublished data), we hypothesized that WT1 might interact with SRY. Expression of the WT1 and SRY genes overlaps during early development of the male gonads. In mice, WT1 is expressed continuously in somatic cells of the gonads from 9.5 d.p.c., whereas Sry is expressed transiently in the same cells from 10.5 to 12.5 d.p.c. (Armstrong et al., 1993; Hacker et al., 1995) . In humans, WT1 expression first appears at 32 days postovulation (d.p.o.) in the gonadal ridges of both male and female embryos and then increases at 41 d.p.o., whereas SRY is most strongly expressed at 44 d.p.o., and both genes are expressed later in fetal development (Hanley et al., 1999 (Hanley et al., , 2000 . Furthermore, mutations in both genes are associated with gonadal dysgenesis in mice and humans as described above. Therefore, we tested the in vitro and in vivo associations of WT1 and SRY ( 35 S-labeled SRY mutant proteins were generated by TnT-coupled reticulocyte lysate systems (Promega), and then almost equal amounts of mutant proteins were incubated with GST beads. Proteins bound to GST beads (lane G) or GST-WT1 beads (lane W) were detected by fluorography. An aliquot (15%) of protein lysates used in the pull-down assay was separated by electrophoresis (lane I). (b) Mapping of the region in WT1 to interact with SRY.
35 S-labeled WT1 deletion mutants bound to GST beads (lane G) or GST-SRY beads (lane S) were detected. Protein lysates (5%) used in the pull-down assay were separated by electrophoresis (lane I). (c) Association of WT1 and SRY in yeast. Yeast two-hybrid assay. A bait plasmid, pLexA-WT1, was constructed as described (Osaki et al., 1999) . A prey plasmid, pSHM-SRYBS, was constructed by inserting the sequence containing the HMG box and C-terminal region of SRY into pSHM.1-LacZ vector (Bio101). Yeast strain L40 was transformed with these plasmids and then monitored for growth on selective medium. (1-139) showed weaker affinities for WT1 than did wildtype SRY, suggesting that the HMG box of SRY is required for WT1 binding and that the C-terminal region may contribute to maximal binding affinity in vitro. Sequences outside the HMG box may contribute to the stability or conformation of the SRY protein, because the level of expression of the C-terminus truncation mutant was lower than that of wildtype SRY in cells (data not shown). HMG box-mediated interactions appear to be significant because only the HMG box is evolutionarily conserved in SRY. We also found that the HMG box of mouse Sry binds to WT1 (data not shown). We then mapped the WT1 interaction domain. As shown in Figure 1b , WT1 mutants (180-429) and (285-429) contain the zinc-finger domain and bound to SRY, whereas WT1 mutants (1-284) and (1-179) lack the zinc-finger domain and did not. Therefore, the zinc-finger domain of WT1 is necessary and sufficient to bind SRY in vitro. Yeast two-hybrid assay revealed that WT1( þ / þ ), which contains 17 and 3 amino-acid insertions and WT1(À/À), which does not contain either insertion, both interact directly with SRY. Thus, alternative splicing does not affect the binding of WT1 to SRY (Figure 1c) . We then examined the WT1-SRY interaction in cultured cells. Since gonadal cell lines that express both SRY and WT1 are not available, we prepared nuclear extracts from 293 T cells transfected with WT1 and SRY expression vectors. As shown in Figure 1d , WT1 was coimmunoprecipitated with SRY from nuclear lysates of cells expressing both proteins. Immunoprecipitation of WT1 was not due to antibody crossreactivity, because WT1 was not precipitated from extracts of cells that did not express SRY. These results suggest that WT1 binds directly to SRY in vitro and in vivo.
Since human SRY does not have a transcriptional regulatory domain, we hypothesized that WT1 might act synergistically with SRY to activate transcription from a promoter containing SRY-binding sites. As shown in Figure 2a , coexpression of WT1 and SRY showed enhanced transcriptional activity from the wildtype reporter in comparison with SRY or WT1 alone. Furthermore, this enhanced transcription was reduced when SRY-binding sites were mutated. We then examined whether DDS mutants of WT1 could activate transcription. The Arg-394 to Trp (RW) and Asp-396 to Asn (DN) DDS mutants of WT1 did not act synergistically with SRY ( Figure 2b ). WT1 isoforms (À/À) and ( þ /À) are thought to regulate transcription by binding directly to DNA, whereas WT1 isoforms (À/ þ ) and ( þ / þ ) show reduced DNA-binding activity and are colocalized preferentially with splicing factors (Larsson et al., 1995) . As shown in Figure 2c , only WT1 (À/À) and ( þ /À) activated transcription; thus, the 17 aminoacid insertion had no effect on this activity. In these experiments, the levels of WT1 isoforms and DDS mutants appeared to be similar (see Figure 3b and c, NE).
To clarify the mechanism underlying the synergistic interaction of WT1 and SRY, we carried out DNA affinity precipitation (DNAP) assays. We amplified the DNA probes from the promoter region of the wildtype and mutant reporter plasmids using 5-biotinylated primers. Since the probe does not contain a WT1-binding site, WT1 hardly bound to the probe in the absence of SRY. WT1 was, however, recruited to the probe DNA in an SRY dose-dependent manner (Figure 3a, DNAP) . When the SRY-binding sequence in the probe was mutated, SRY did not bind to the probe efficiently, and accordingly WT recruitment was reduced. The sex-reversal mutant SRY (Gly-95 to Arg, GR), which does not bind DNA , did not recruit WT1 efficiently to the probe, although the amount of WT1-SRY complex was similar between wildtype-and mutant SRY-expressing cells (Figure 3a , compare the lanes shown by * and #). Control experiments using a cAMP-responsive element (CRE) as a probe did not show any recruitment of WT1 to CRE even when CREB was overexpressed (data not shown). DDS mutants of WT1 (RW and DN) also did not form a stable complex on DNA (Figure 3b ). WT1ÀKTS isoforms (À/À) and ( þ /À) were recruited to DNA more efficiently than were WT1 þ KTS isoforms (À/ þ ) and ( þ / þ ) (Figure 3c ). In addition, an inframe deletion of the third zinc-finger mutant, DF3, was not recruited to DNA, indicating that an intact zincfinger domain is necessary for WT1-SRY interaction.
The correlation of WT1 recruitment to DNA with the synergistic effect of WT1 and SRY on transcription suggests that WT1-KTS isoforms enhance transcription from SRY-binding sites through the formation of a protein complex containing SRY and WT1 on the DNA. Since both WT1( þ / þ ) and WT1(À/À) bound to SRY (Figure 1c ), binding itself is not sufficient, and an additional component may be required for WT1 recruitment to DNA. In fact, WT1 recruitment was not detected when purified WT1 zinc-finger domain and SRY were mixed (data not shown). Analysis of protein complexes containing WT1 and SRY will be necessary to clarify the molecular mechanism of WT1-mediated transactivation.
Our findings suggest two modes of transcriptional regulation by WT1. One is mediated by direct binding to DNA, and the other is through protein-protein interactions with other transcription factors, including SRY and Ad4BP/SF-1. A synergistic interaction between WT1 and Ad4BP/SF-1 is thought to be important for regulation of the MIS gene. Target genes for SRY have not been analysed because significant transcriptional activity of SRY has not been detected. The synergy between WT1 and SRY will enable us to identify genes downstream of SRY, which will be necessary to understand the physiological and pathological mechanisms underlying testis development. critical reading of the manuscript. A Aono, N Hoshina, T Kimura, Y Wakabayashi, and M Yoshikawa provided excellent technical assistance. This work was supported by a grant provided by the Ichiro Kanehara Foundation (99KI005) and by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. 
